HLCR011 / Sumitomo Pharma, Healios, RACTHERA - LARVOL DELTA

Technique of RPE cell administration to prevent ERM formation. (ARVO 2023) - "Following vitrectomy, a suspension of HLCR011 human induced pluripotent stem (hiPS) cell-derived RPE cells was administered (5.0×10 5 cells in 50 µL/eye) with a 38G subretinal cannula via the vitreous cavity into the right eyes of cyclosporin A-immunosuppressed monkeys...Layman Abstract (optional): Provide a 50-200 word description of your work that non-scientists can understand. Describe the big picture and the implications of your findings, not the study itself and the associated details."

Ophthalmology • Retinal Disorders • PMEL